203 related articles for article (PubMed ID: 35550008)
1. Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
Le Vely B; Phan C; Berrebeh N; Thuillet R; Ottaviani M; Chelgham MK; Chaumais MC; Amazit L; Humbert M; Huertas A; Guignabert C; Tu L
Am J Respir Cell Mol Biol; 2022 Aug; 67(2):215-226. PubMed ID: 35550008
[TBL] [Abstract][Full Text] [Related]
2. Impaired Interleukin-15 Signaling via
Hilton LR; Rätsep MT; VandenBroek MM; Jafri S; Laverty KJ; Mitchell M; Theilmann AL; Smart JA; Hawke LG; Moore SD; Renaud SJ; Soares MJ; Morrell NW; Ormiston ML
Hypertension; 2022 Nov; 79(11):2493-2504. PubMed ID: 36043416
[TBL] [Abstract][Full Text] [Related]
3.
Hong J; Wong B; Huynh C; Tang B; Ruffenach G; Li M; Umar S; Yang X; Eghbali M
Am J Respir Cell Mol Biol; 2023 Apr; 68(4):381-394. PubMed ID: 36252184
[TBL] [Abstract][Full Text] [Related]
4. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
Born E; Lipskaia L; Breau M; Houssaini A; Beaulieu D; Marcos E; Pierre R; Do Cruzeiro M; Lefevre M; Derumeaux G; Bulavin DV; Delcroix M; Quarck R; Reen V; Gil J; Bernard D; Flaman JM; Adnot S; Abid S
Circulation; 2023 Feb; 147(8):650-666. PubMed ID: 36515093
[TBL] [Abstract][Full Text] [Related]
5. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.
Caruso P; Dunmore BJ; Schlosser K; Schoors S; Dos Santos C; Perez-Iratxeta C; Lavoie JR; Zhang H; Long L; Flockton AR; Frid MG; Upton PD; D'Alessandro A; Hadinnapola C; Kiskin FN; Taha M; Hurst LA; Ormiston ML; Hata A; Stenmark KR; Carmeliet P; Stewart DJ; Morrell NW
Circulation; 2017 Dec; 136(25):2451-2467. PubMed ID: 28971999
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.
Rodor J; Chen SH; Scanlon JP; Monteiro JP; Caudrillier A; Sweta S; Stewart KR; Shmakova A; Dobie R; Henderson BEP; Stewart K; Hadoke PWF; Southwood M; Moore SD; Upton PD; Morrell NW; Li Z; Chan SY; Handen A; Lafyatis R; de Rooij LPMH; Henderson NC; Carmeliet P; Spiroski AM; Brittan M; Baker AH
Cardiovasc Res; 2022 Aug; 118(11):2519-2534. PubMed ID: 34528097
[TBL] [Abstract][Full Text] [Related]
7. E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.
Yi D; Liu B; Ding H; Li S; Li R; Pan J; Ramirez K; Xia X; Kala M; Ye Q; Lee WH; Frye RE; Wang T; Zhao Y; Knox KS; Glembotski CC; Fallon MB; Dai Z
Hypertension; 2023 Nov; 80(11):2357-2371. PubMed ID: 37737027
[TBL] [Abstract][Full Text] [Related]
8. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
9. Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.
Wu Y; Pan B; Zhang Z; Li X; Leng Y; Ji Y; Sun K; Chen AF
Hypertension; 2022 Mar; 79(3):536-548. PubMed ID: 34984912
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
12. A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
Tu L; De Man FS; Girerd B; Huertas A; Chaumais MC; Lecerf F; François C; Perros F; Dorfmüller P; Fadel E; Montani D; Eddahibi S; Humbert M; Guignabert C
Am J Respir Crit Care Med; 2012 Oct; 186(7):666-76. PubMed ID: 22798315
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
[TBL] [Abstract][Full Text] [Related]
14. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway.
Liu Y; Tang BL; Lu ML; Wang HX
J Cell Mol Med; 2023 Mar; 27(5):622-633. PubMed ID: 36762748
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
[TBL] [Abstract][Full Text] [Related]
17. ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
Liu B; Azfar M; Legchenko E; West JA; Martin S; Van den Haute C; Baekelandt V; Wharton J; Howard L; Wilkins MR; Vangheluwe P; Morrell NW; Upton PD
Cardiovasc Res; 2024 May; 120(7):756-768. PubMed ID: 38626311
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension.
Lavoie JR; Ormiston ML; Perez-Iratxeta C; Courtman DW; Jiang B; Ferrer E; Caruso P; Southwood M; Foster WS; Morrell NW; Stewart DJ
Circulation; 2014 May; 129(21):2125-35. PubMed ID: 24657995
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
[TBL] [Abstract][Full Text] [Related]
20. A Potential Role for Exosomal Translationally Controlled Tumor Protein Export in Vascular Remodeling in Pulmonary Arterial Hypertension.
Ferrer E; Dunmore BJ; Hassan D; Ormiston ML; Moore S; Deighton J; Long L; Yang XD; Stewart DJ; Morrell NW
Am J Respir Cell Mol Biol; 2018 Oct; 59(4):467-478. PubMed ID: 29676587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
